Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation - Trial NCT02654561
Access comprehensive clinical trial information for NCT02654561 through Pure Global AI's free database. This Phase 3 trial is sponsored by China Medical University, China and is currently status unknown. The study focuses on Sepsis,Disseminated Intravascular Coagulation. Target enrollment is 700 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
China Medical University, China
Timeline & Enrollment
Phase 3
Apr 20, 2017
Jun 01, 2021
Primary Outcome
ICU mortality
Summary
The primary objective of this study is to estimate the efficacy of unfractionated
 heparin(UFH) on ICU mortality in severe sepsis with suspected DIC.The Second objective is to
 estimate the effect of UFH on 28-day mortality,and the change of the Japanese Association for
 Acute Medicine(JAAM) score and SOFA score. The third one is to evaluate the safety of UFH in
 severe sepsis patients with suspected DIC.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02654561
Non-Device Trial